Related Experiment Video
Updated: Jun 5, 2026

10:41
A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
Published on: April 30, 2020
A follow up study on revised national tuberculosis control programme (rntcp): results from a single centre study
R Prasad1, S K Verma, P Shrivastava
1Department of Pulmonary Medicine, CSMMU, UP, Lucknow, India.
Lung India : Official Organ of Indian Chest Society
|January 26, 2011
Summary
Most tuberculosis patients remain asymptomatic one year after completing treatment under the Directly Observed Treatment, Short-course (DOTS) program. This follow-up study confirms high treatment success rates and low relapse rates in tuberculosis management.
Area of Science:
- Public Health
- Infectious Diseases
- Clinical Medicine
Background:
- Tuberculosis (TB) remains a significant global health challenge.
- Effective treatment and follow-up are crucial for patient outcomes and disease control.
- The Revised National Tuberculosis Control Programme (RNTCP) in India utilizes Directly Observed Treatment, Short-course (DOTS).
Purpose of the Study:
- To assess the long-term follow-up status of tuberculosis patients one year post-treatment completion.
- To evaluate treatment outcomes including asymptomatic status, relapse, and mortality within the RNTCP framework.
Main Methods:
- A cohort of TB patients registered between June 2003 and June 2004 was followed up one year after treatment completion.
- Home visits by health visitors were conducted for clinical assessment.
- Symptomatic patients underwent radiological and bacteriological evaluation.
Main Results:
- Out of 212 patients who completed treatment, 152 were interviewed after one year.
- 137 patients (90.1%) remained asymptomatic.
- 11 patients (7.2%) relapsed, and 4 patients (2.6%) died during the follow-up period.
Conclusions:
- The majority of tuberculosis patients (90.1%) remain asymptomatic one year after completing treatment under DOTS.
- The DOTS strategy demonstrates high effectiveness in achieving sustained positive outcomes for TB patients.
- Long-term follow-up is essential for monitoring TB treatment success and identifying potential relapses.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...